Back to Companies
X4 Pharmaceuticals, Inc
XFORNasdaqCIK: 0001501697
Over the 16 most recent insider filings, X4 Pharmaceuticals, Inc (XFOR) has seen activity from 5 distinct insiders — 1 buying and 2 selling. The activity is a roughly balanced mix of buying and selling: $250.0K bought versus $356.5K sold, net sales of $106.5K. Craig Adam R (Executive Chairman, Director) is the most active by dollar volume, and the single largest transaction was $3.9M by Volpone John. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$20.8M
Purchases
$250.0K
Sales
$356.5K
Unique Insiders
5
Recent Insider Trades
16 loaded
| Aug 13 | XFOR X4 Pharmaceuticals, Inc | Craig Adam R | Executive Chairman, Director | Sell | $210.8K |
| Aug 13 | XFOR X4 Pharmaceuticals, Inc | Volpone John | President | Sell | $109.2K |
| Jul 1 | XFOR X4 Pharmaceuticals, Inc | Gold Kelly | Director | Other | $0 |
| Jul 1 | XFOR X4 Pharmaceuticals, Inc | Gold Kelly | Director | Award | $449.4K |
| Jul 1 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Sell | $36.4K |
| Jan 5 | XFOR X4 Pharmaceuticals, Inc | WYZGA MICHAEL S | Director | Award | $440.0K |
| Oct 31 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Award | $2.2M |
| Oct 31 | XFOR X4 Pharmaceuticals, Inc | Craig Adam R | Executive Chairman, Director | Award | $3.3M |
| Oct 31 | XFOR X4 Pharmaceuticals, Inc | Volpone John | President | Award | $3.3M |
| Oct 27 | XFOR X4 Pharmaceuticals, Inc | Craig Adam R | Executive Chairman, Director | Buy | $250.0K |
| Aug 14 | XFOR X4 Pharmaceuticals, Inc | Volpone John | President | Grant | $3.9M |
| Aug 14 | XFOR X4 Pharmaceuticals, Inc | Craig Adam R | Executive Chairman, Director | Other | $0 |
| Aug 14 | XFOR X4 Pharmaceuticals, Inc | Volpone John | President | Other | $0 |
| Aug 14 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Grant | $2.6M |
| Aug 14 | XFOR X4 Pharmaceuticals, Inc | Craig Adam R | Executive Chairman, Director | Grant | $3.9M |
| Aug 14 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Other | $0 |
16 filings